New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sulfadiazine silver 1%{relative} - topical cream - 1% w/w - active: sulfadiazine silver 1%{relative}

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - diclofenac sodium - suppository - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - diclofenac sodium - suppository - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - diclofenac sodium - suppository - 100mg

United States - English - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 g in 1000 g - silver sulfadiazine 1% cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. silver sulfadiazine 1% cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine 1% cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine 1% cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. silver sulfadiazine 1% cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine 1% cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.